KDM2A脱甲酶:在发育,癌症和治疗视野中是一种多功能表观遗传调节剂
Tajrin Sultana1, Md Sadikul Islam2, S M Abdus Salam3
1Department of Anatomy, School of Medicine, Wonkwang University, Iksan 54538, South Korea.
Pathology, research and practice
|December 18, 2025
概括
氨酸脱甲基酶2A (KDM2A) 是表观遗传调节的关键,影响发育和疾病. 它在癌症中的双重作用为表观遗传疗法提供了复杂的治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 氨酸脱甲基酶2A (KDM2A) 是一种对表观遗传调节至关重要的基因组脱甲基酶.
- 它改变了基因组甲基化和染色质结构,影响了基因表达和基因组稳定性.
- KDM2A在发育,分化,新陈代谢和DNA损伤反应中起作用.
研究的目的:
- 在正常和疾病状态下审查KDM2A的多方面的表观遗传功能.
- 概述KDM2A失调对疾病的相关影响,特别是在癌症中.
- 总结KDM2A向疗法及其临床潜力.
主要方法:
- 对KDM2A在表观遗传学和疾病中的作用的文献综述.
- 对KDM2A参与基因调节,发育和癌症进展的分析.
- 目前和新兴的针对KDM2A的治疗策略的摘要.
主要成果:
- KDM2A失调与发育障碍和癌症有关.
- 它影响瘤发育,癌症干细胞维护,EMT和代谢重编程.
- KDM2A表现出取决于环境的致癌和瘤抑制功能.
结论:
- KDM2A是一个重要的表观遗传调节器,在疾病中起着复杂的作用.
- 它的双重功能为向治疗带来了挑战和机遇.
- KDM2A调制对治疗癌症和其他表观遗传相关疾病充满希望.
相关概念视频
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
M-Cdk Drives Transition Into Mitosis
6.2K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K


